99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer

NCT04233476 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

409

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Lymph Node Metastasis

Interventions

DRUG: 99mTc-3PRGD2 injection

Sponsor

RDO Pharm.

Collaborators

[object Object]